{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:49:21Z","timestamp":1784130561123,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["domesticanimalendo.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.domaniend.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T11:46:33Z","timestamp":1399635993000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats"],"prefix":"10.1016","volume":"49","author":[{"given":"N.","family":"Nishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Murahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matsuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Hikasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.domaniend.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.domaniend.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.domaniend.2013.04.004","article-title":"Distribution of K and L cells in the feline intestinal tract","volume":"45","author":"Gilor","year":"2013","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.domaniend.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.domaniend.2011.01.002","article-title":"The incretin effect in cats: comparison between oral glucose, lipids, and amino acids","volume":"40","author":"Gilor","year":"2011","journal-title":"Domest Anim Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.domaniend.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0168-8227(11)70011-0","article-title":"Incretin effect: GLP-1, GIP, DPP4","volume":"93","author":"Kazakos","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.domaniend.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2337\/db09-1414","article-title":"The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action","volume":"59","author":"Hare","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.domaniend.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"Deacon","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.domaniend.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in\u00a0vitro and in\u00a0vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2014.04.006_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clpt.2005.09.002","article-title":"Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses","volume":"78","author":"Herman","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.domaniend.2014.04.006_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygcen.2012.11.019","article-title":"Diabetes from humans to cats","volume":"182","author":"Osto","year":"2013","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib13","series-title":"Small animal clinical nutrition","author":"Hand","year":"2010"},{"key":"10.1016\/j.domaniend.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1292\/jvms.71.1005","article-title":"A novel sandwich enzyme-linked immunosorbent assay for feline insulin","volume":"71","author":"Nakaya","year":"2009","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.domaniend.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1292\/jvms.10-0414","article-title":"Insulin responses to administrations of amino acids and fatty acids in healthy cats","volume":"73","author":"Yasuda","year":"2011","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.domaniend.2014.04.006_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.domaniend.2009.08.004","article-title":"Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats","volume":"38","author":"Hoenig","year":"2010","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/db07-0100","article-title":"Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?","volume":"56","author":"Knop","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.domaniend.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3945\/ajcn.2008.26720","article-title":"Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver","volume":"89","author":"Musso","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.domaniend.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","article-title":"Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects","volume":"89","author":"Greenfield","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.domaniend.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0091270006289850","article-title":"Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects","volume":"46","author":"Herman","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinthera.2006.01.015","article-title":"Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers","volume":"28","author":"Bergman","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.domaniend.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0026-0495(93)90001-5","article-title":"Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients","volume":"42","author":"Dupr\u00e9","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.domaniend.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","article-title":"Nutritional regulation of glucagon-like peptide-1 secretion","volume":"587","author":"Tolhurst","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365529609009147","article-title":"Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day","volume":"31","author":"Orskov","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.domaniend.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmet.2008.11.004","article-title":"A gut feeling for obesity: 7TM sensors on enteroendocrine cells","volume":"8","author":"Engelstoft","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.domaniend.2014.04.006_bib26","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1210\/jc.2012-3996","article-title":"Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans","volume":"98","author":"Lindqvist","year":"2013","journal-title":"J Clin Encocrinol Metab"},{"key":"10.1016\/j.domaniend.2014.04.006_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI112855","article-title":"Insulinotropin: glucagon-like peptide 1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas","volume":"79","author":"Mojsov","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.domaniend.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.domaniend.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073972401400040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073972401400040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T09:42:26Z","timestamp":1565430146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073972401400040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":29,"alternative-id":["S073972401400040X"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2014.04.006","relation":{},"ISSN":["0739-7240"],"issn-type":[{"value":"0739-7240","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}